Kimon Bekelis1,2, Dan Gottlieb2, Yin Su2, Nicos Labropoulos3, George Bovis4, Michael T Lawton5, Todd A MacKenzie6,7,8,2,9. 1. Section of Neurosurgery, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA. 2. The Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, New Hampshire, USA. 3. Department of Radiology, Stony Brook University Medical Center, Stony Brook, New York, USA. 4. Department of Neurosurgery, Rush University Medical Center, Chicago, Illinois, USA. 5. Department of Neurosurgery, University of California, San Francisco Medical Center, San Francisco, California, USA. 6. Department of Biomedical Data Science, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA. 7. Department of Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA. 8. Department of Community and Family Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA. 9. Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.
Abstract
BACKGROUND: The cost difference between the two treatment options (surgical clipping and endovascular therapy) for unruptured cerebral aneurysms remains an issue of debate. We investigated the association between treatment method for unruptured cerebral aneurysms and Medicare expenditures in elderly patients. METHODS: We performed a cohort study of 100% Medicare fee-for-service claims data for elderly patients who underwent treatment for unruptured cerebral aneurysms from 2007 to 2012. In order to control for measured confounding we used multivariable regression analysis with mixed effects to account for clustering at the Hospital Referral Region (HRR) level. An instrumental variable (regional rates of endovascular treatment) analysis was used to control for unmeasured confounding by creating pseudo-randomization on the treatment method. RESULTS: During the study period 8705 patients underwent treatment for unruptured cerebral aneurysms and met the inclusion criteria. Of these, 2585 (29.7%) had surgical clipping and 6120 (70.3%) had endovascular treatment. The median total Medicare expenditures in the first year after the admission for the procedure were $46 800 (IQR $31 000-$74 400) for surgical clipping and $48 100 (IQR $34 500-$73 900) for endovascular therapy. When we adjusted for unmeasured confounders, using an instrumental variable analysis, clipping was associated with increased 7-day Medicare expenditures by $3527 (95% CI $972 to $5736) and increased 1-year Medicare expenditures by $15 984 (95% CI $9017 to $22 951). CONCLUSIONS: In a cohort of Medicare patients, after controlling for unmeasured confounding, we demonstrated that surgical clipping of unruptured cerebral aneurysms was associated with increased 1-year expenditures compared with endovascular treatment. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
BACKGROUND: The cost difference between the two treatment options (surgical clipping and endovascular therapy) for unruptured cerebral aneurysms remains an issue of debate. We investigated the association between treatment method for unruptured cerebral aneurysms and Medicare expenditures in elderly patients. METHODS: We performed a cohort study of 100% Medicare fee-for-service claims data for elderly patients who underwent treatment for unruptured cerebral aneurysms from 2007 to 2012. In order to control for measured confounding we used multivariable regression analysis with mixed effects to account for clustering at the Hospital Referral Region (HRR) level. An instrumental variable (regional rates of endovascular treatment) analysis was used to control for unmeasured confounding by creating pseudo-randomization on the treatment method. RESULTS: During the study period 8705 patients underwent treatment for unruptured cerebral aneurysms and met the inclusion criteria. Of these, 2585 (29.7%) had surgical clipping and 6120 (70.3%) had endovascular treatment. The median total Medicare expenditures in the first year after the admission for the procedure were $46 800 (IQR $31 000-$74 400) for surgical clipping and $48 100 (IQR $34 500-$73 900) for endovascular therapy. When we adjusted for unmeasured confounders, using an instrumental variable analysis, clipping was associated with increased 7-day Medicare expenditures by $3527 (95% CI $972 to $5736) and increased 1-year Medicare expenditures by $15 984 (95% CI $9017 to $22 951). CONCLUSIONS: In a cohort of Medicare patients, after controlling for unmeasured confounding, we demonstrated that surgical clipping of unruptured cerebral aneurysms was associated with increased 1-year expenditures compared with endovascular treatment. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
Authors: Tim E Darsaut; Laurent Estrade; Sara Jamali; Michel W Bojanowski; Miguel Chagnon; Jean Raymond Journal: J Neurosurg Date: 2014-01-03 Impact factor: 5.115
Authors: Waleed Brinjikji; Alejandro A Rabinstein; Giuseppe Lanzino; David F Kallmes; Harry J Cloft Journal: Stroke Date: 2011-03-24 Impact factor: 7.914
Authors: Jennifer S McDonald; Robert J McDonald; Jiaquan Fan; David F Kallmes; Giuseppe Lanzino; Harry J Cloft Journal: Stroke Date: 2013-02-28 Impact factor: 7.914
Authors: Jane Wolstenholme; Oliver Rivero-Arias; Alastair Gray; Andrew J Molyneux; Richard S C Kerr; Julia A Yarnold; Mary Sneade Journal: Stroke Date: 2007-11-29 Impact factor: 7.914